Physician profile
Arnold Hoo Seto
NPI 1215081807
$213,718.97
in general payments reported to CMS, 2019-2025
50 companies · $8,209 in 2025
The $8,209 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $19K · 2021: $49K · 2022: $46K · 2023: $18K · 2024: $13K · 2025: $8,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Consulting Fee: $13K · Food and Beverage: $4,974 · Travel and Lodging: $1,714 · Entertainment: $15.79 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,821.00 |
| Consulting Fee | $12,946.83 |
| Food and Beverage | $4,973.95 |
| Travel and Lodging | $1,713.99 |
| Entertainment | $15.79 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $145,066.77 | 2019-2024 | Xarelto |
| Terumo Medical Corporation | $16,588.95 | 2019-2025 | Optitorque, Glidesheath Slender, R2p Misago |
| Getinge USA Sales, LLC | $8,724.32 | 2019-2023 | Vasoview Hemopro 2 |
| Boston Scientific Corporation | $6,632.84 | 2019-2025 | Rotapro, Watchman Flx |
| Ge Healthcare | $6,317.13 | 2020-2024 | |
| Opsens INC. | $6,163.75 | 2019-2023 | Optowire |
| Merit Medical Systems INC | $3,778.91 | 2025 | |
| Acist Medical Systems, INC. | $3,493.85 | 2020-2021 | |
| Janssen Global Services, LLC | $3,100.00 | 2022 | |
| Medtronic, INC. | $2,428.59 | 2021-2023 | Corevalve Evolut R |
| Abbott Laboratories | $1,886.80 | 2019-2025 | Aveir, Optis |
| Philips North America LLC | $1,687.50 | 2019 | |
| Maquet Cardiovascular L.L.C. | $1,600.00 | 2023 | Vasoview Hemopro 2 |
| Cordis US Corp. | $638.23 | 2022-2023 | Mynx Control |
| Datascope Corp. | $555.11 | 2019-2025 | Cardiosave Rescue, Mega 7.5fr. 40cc Iab With Accessories (Apa), US Only |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $528.86 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medicure Pharma INC. | $500.00 | 2021 | |
| Recor Medical INC | $480.02 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cathworks, INC. | $418.57 | 2022-2023 | Ffrangio |
| Biolife, L.L.C. | $374.80 | 2025 | |
| Impulse Dynamics (USA) INC. | $289.93 | 2021-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $287.14 | 2019-2025 | Lifevest |
| Penumbra, INC. | $234.54 | 2022 | |
| Abiomed | $229.80 | 2021-2025 | Impella |
| Neovasc Medical INC | $210.30 | 2022 | |
| Atricure, INC. | $193.60 | 2024-2025 | Atriclip Laa Exclusion System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.18 | 2019-2025 | Jardiance |
| Zoll Respicardia, INC. | $149.01 | 2019 | |
| Edwards Lifesciences Corporation | $124.87 | 2019 | |
| Pfizer INC. | $100.49 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $96.27 | 2019-2025 | Eliquis |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $68.37 | 2020-2025 | Andexxa, Wainua |
| Kiniksa Pharmaceuticals, LTD. | $61.63 | 2022-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $56.97 | 2020-2025 | Amvuttra |
| Actelion Pharmaceuticals US, INC. | $56.68 | 2023 | Opsumit, Uptravi |
| Bardy Diagnostics, INC. | $56.33 | 2020-2021 | |
| Lantheus Medical Imaging, INC. | $45.81 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $34.61 | 2023 | Inpefa |
| Irhythm Technologies, INC. | $27.87 | 2019 | |
| Teleflex LLC | $26.63 | 2022 | |
| Altathera Pharmaceuticals LLC | $26.44 | 2025 | Sotalol Hydrochloride |
| Amgen INC. | $24.20 | 2025 | |
| Sanofi-Aventis U.S. LLC | $23.99 | 2023 | |
| Bridgebio Pharma, INC. | $23.26 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $21.73 | 2022 | |
| Medtronic Vascular, INC. | $15.05 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Seto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.